Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 6,432Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 20AMGEN INC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

IVABRADINE HYDROCHLORIDE

US Patent Number : 7867996

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 206143

Patent Use Code : U-1694

Delist Requested :

Patent Use Description : A METHOD FOR TREATING ...

Patent Expiration Date : 2026-12-12

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

IVABRADINE HYDROCHLORIDE

US Patent Number : 7361649

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 206143

Patent Use Code : U-1694

Delist Requested :

Patent Use Description : A METHOD FOR TREATING ...

Patent Expiration Date : 2026-02-22

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

IVABRADINE HYDROCHLORIDE

US Patent Number : 7879842

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 206143

Patent Use Code : U-1694

Delist Requested :

Patent Use Description : A METHOD FOR TREATING ...

Patent Expiration Date : 2026-02-22

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

IVABRADINE HYDROCHLORIDE

US Patent Number : 7361649

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 206143

Patent Use Code : U-1694

Delist Requested :

Patent Use Description : A METHOD FOR TREATING ...

Patent Expiration Date : 2026-02-22

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

IVABRADINE HYDROCHLORIDE

US Patent Number : 7879842

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 206143

Patent Use Code : U-1694

Delist Requested :

Patent Use Description : A METHOD FOR TREATING ...

Patent Expiration Date : 2026-02-22

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

IVABRADINE

US Patent Number : 7867996

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 209964

Patent Use Code : U-1694

Delist Requested :

Patent Use Description : A METHOD FOR TREATING ...

Patent Expiration Date : 2026-12-12

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

IVABRADINE

US Patent Number : 7361650

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 209964

Patent Use Code : U-1694

Delist Requested :

Patent Use Description : A METHOD FOR TREATING ...

Patent Expiration Date : 2026-02-22

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

IVABRADINE

US Patent Number : 7361649

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 209964

Patent Use Code : U-1694

Delist Requested :

Patent Use Description : A METHOD FOR TREATING ...

Patent Expiration Date : 2026-02-22

blank

09

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

IVABRADINE HYDROCHLORIDE

US Patent Number : 7361650

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 206143

Patent Use Code : U-1694

Delist Requested :

Patent Use Description : A METHOD FOR TREATING ...

Patent Expiration Date : 2026-02-22

blank

10

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

IVABRADINE HYDROCHLORIDE

US Patent Number : 7361650

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 206143

Patent Use Code : U-1694

Delist Requested :

Patent Use Description : A METHOD FOR TREATING ...

Patent Expiration Date : 2026-02-22

blank